PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 54 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

18 January 2025

  1. (diff | hist) 13:05 Peptide aggregation 3,115 ±0 Chromatokid (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  2. (diff | hist) 12:49 Qingdao Sigma Chemical 7,484 +144 GradientGus (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  3. (diff | hist) 11:35 Talk:Bachem Holding (Suzhou) 1,033 +288 CoI_Corin (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  4. (diff | hist) 10:21 Nantong Guangyuan Chemical 8,038 +986 Chromatokid (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  5. (diff | hist) 09:19 Amylin receptor agonist 3,532 +27 LedeLeander (talk | contribs) clarify that the peptide backbone is acylated rather than PEGylated [rollback]
  6. (diff | hist) m 07:11 Guangzhou JEEP Biotechnology 8,327 +522 PurityClaimPia (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  7. (diff | hist) 05:43 Sangon Biotech 4,809 +912 TallySheetTad (talk | contribs) split §Operations from §Product range [rollback]
  8. (diff | hist) 04:04 Cost per milligram 1,884 +375 SurmountSurma (talk | contribs) expand §Other axes that a price hides [rollback]
  9. (diff | hist) 01:08 Trifluoroacetate counterion 3,356 +617 AnalyticalAnnie (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  10. (diff | hist) 00:11 Adverse effects of GLP-1 receptor agonists 4,482 ±0 PancreasPru (talk | contribs) expand §Less common but significant [rollback]

17 January 2025

  1. (diff | hist) m 20:12 Good manufacturing practice 3,330 +792 ShortageShona (talk | contribs) rm the claim that the position has changed; no source supports it [rollback]
  2. (diff | hist) 17:41 C-peptide 3,250 +677 DrTitration (talk | contribs) clarify that the marker is method-dependent and not comparable across platforms [rollback]
  3. (diff | hist) 09:52 Talk:Bachem Holding (Suzhou) 822 +214 Hedgerow_Hal (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  4. (diff | hist) m 08:15 Global access disparity 1,977 ±0 TelehealthTruus (talk | contribs) de-duplicate a repeated sentence [rollback]
  5. (diff | hist) 04:29 GL Biochem (Shanghai) 9,579 +110 TrialsTabitha (talk | contribs) expand §Operations and documentation practice [rollback]
  6. (diff | hist) 03:05 Bachem Holding (Suzhou) 6,630 +531 VerifyFirstVida (talk | contribs) state the city and province of the registered address [rollback]
  7. (diff | hist) 02:45 Wuhan Wansheng Biotechnology 9,212 +1,308 VerifyVesna (talk | contribs) rm a duplicated category [rollback]
  8. (diff | hist) 00:57 Amylin 3,933 +107 FmocFrancis (talk | contribs) add category for the drug class [rollback]
  9. (diff | hist) m 00:08 Shanghai Wibson Biotechnology 1,761 ±0 PurityClaimPia (talk | contribs) consistent en dashes in ranges [rollback]

16 January 2025

  1. (diff | hist) m 20:59 Beta cell function 4,328 +92 LabRangeLindy (talk | contribs) expand §What is being measured [rollback]
  2. (diff | hist) m 17:13 Weight regain after discontinuation 3,570 ±0 MTC_Marisol (talk | contribs) add the placebo rate next to the treatment rate [rollback]
  3. (diff | hist) 15:00 Insulin syringe 3,777 ±0 UnitAuditUwe (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 13:07 Talk:Bachem Holding (Suzhou) 611 +299 NPOV_Nadia (talk | contribs) /* The name coincidence: how much should the article say? */ reply
  5. (diff | hist) 11:09 Missed dose 3,387 +32 RotationRosalind (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]
  6. (diff | hist) 10:29 Talk:Bachem Holding (Suzhou) 400 +484 RfC_Rasmus (talk | contribs) /* The name coincidence: how much should the article say? */ new section
  7. (diff | hist) 08:47 Talk:Certificate of analysis 959 +178 ChainCustodyChad (talk | contribs) /* The seven-field table */ reply
  8. (diff | hist) 03:35 PeptideMeter 3,734 +309 GroupBuyGalen (talk | contribs) state what the certificate actually carries, field by field [rollback]
  9. (diff | hist) 01:01 Counterfeit peptide 2,733 +411 BiliaryBea (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]

15 January 2025

  1. (diff | hist) m b 23:29 Peptide synthesis 4,113 +332 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  2. (diff | hist) 21:47 Shanghai Sigma-Audley New Material Technology 6,202 +1,157 TallySheetTad (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  3. (diff | hist) 21:42 Grey market 2,576 +445 RfC_Rasmus (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  4. (diff | hist) 16:24 Mass spectrometry 4,327 ±0 ArcuateArt (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  5. (diff | hist) m b 15:37 ISO 9001 3,129 +127 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 14:02 Talk:Certificate of analysis 748 +286 StyleSheetSybil (talk | contribs) /* The seven-field table */ reply
  7. (diff | hist) 11:57 Loss on drying 3,338 +124 Chromatokid (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  8. (diff | hist) 11:39 Baseline laboratory panel 2,337 ±0 DrTitration (talk | contribs) clarify that the reference interval is not a treatment target [rollback]
  9. (diff | hist) 09:33 Talk:Certificate of analysis 537 +153 DefinedTermDov (talk | contribs) /* The seven-field table */ new section
  10. (diff | hist) 02:03 Prior authorisation 2,004 +212 OffLabelOdile (talk | contribs) expand §Variation [rollback]
  11. (diff | hist) 00:21 Sterility testing 3,085 +471 ArchiveAudit (talk | contribs) add category for method validation [rollback]

14 January 2025

  1. (diff | hist) m 23:44 Fasting insulin 2,290 +36 API_Aurora (talk | contribs) clarify that the reference interval is not a treatment target [rollback]
  2. (diff | hist) 22:40 Karl Fischer titration 6,021 ±0 AAA_Analyst (talk | contribs) sentence case in headings per PP:MOS [rollback]
  3. (diff | hist) 16:17 Placebo-adjusted effect 2,853 ±0 SurmountSurma (talk | contribs) add the number randomised and the number completing [rollback]
  4. (diff | hist) m 15:35 Patent expiry and biosimilars 2,578 +736 TrialsTabitha (talk | contribs) add the citation for the regulatory action [rollback]
  5. (diff | hist) N 14:30 Shanghai Wibson Biotechnology 1,761 +1,761 TallySheetTad (talk | contribs) start organisation article — registry facts and product scope only
  6. (diff | hist) m 08:18 Cold-chain freight 3,085 +574 CostPerMgCory (talk | contribs) state that overlay gas is used and name it [rollback]
  7. (diff | hist) m b 04:45 Receptor bias 3,152 +38 CategoryBot (talk | contribs) bot: expand PMID to full citation [rollback]
  8. (diff | hist) 02:33 Growth hormone secretagogue 2,721 ±0 SemaxSevi (talk | contribs) the lead said "widely used"; replaced with what the sources actually support [rollback]

13 January 2025

  1. (diff | hist) 23:19 Lyophilisation 15,434 +1,940 OpenLabelOtto (talk | contribs) sentence case in headings per PP:MOS [rollback]
  2. (diff | hist) 22:39 Contract development and manufacturing organisation 2,875 +29 TitrationTheo (talk | contribs) split §Cold chain from §Storage after receipt [rollback]
  3. (diff | hist) m 18:33 Janoshik Analytical 4,126 +388 AnalyticalAnnie (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  4. (diff | hist) m 16:03 Exenatide 3,419 +30 INN_Ingrid (talk | contribs) expand §The extended-release formulation [rollback]
  5. (diff | hist) 14:54 Medutest 3,513 +22 SortKeySascha (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  6. (diff | hist) 13:03 Dipeptidyl peptidase-4 5,763 +856 HalfLifeHavel (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  7. (diff | hist) 11:32 Peptide content 4,810 +716 Chromatokid (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  8. (diff | hist) 11:02 Incretin effect 5,397 +218 Chromatokid (talk | contribs) ce per PP:MOS [rollback]
  9. (diff | hist) 09:45 Beyond-use date 8,887 +1,138 LyophilLena (talk | contribs) space between number and unit per PP:MOS [rollback]
  10. (diff | hist) 08:46 Global access disparity 1,977 ±0 OffLabelOdile (talk | contribs) clarify that the figures are for one country only [rollback]
  11. (diff | hist) 05:15 Vial 16,052 +509 ResinRhoswen (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]
  12. (diff | hist) m 02:20 Gastric emptying 4,636 +660 GsCouplingGil (talk | contribs) add the citation for the co-secretion finding [rollback]

12 January 2025

  1. (diff | hist) 20:13 Test report forgery 3,609 +700 NAION_Noel (talk | contribs) add the turnaround time the service publishes [rollback]
  2. (diff | hist) 19:49 International nonproprietary name 2,755 ±0 OralSemaOswin (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  3. (diff | hist) m 19:24 Contraindications of incretin therapy 2,653 ±0 PuffRemoverPax (talk | contribs) add the note that titration exists partly to manage these effects [rollback]
  4. (diff | hist) m 09:25 Reference standard 3,767 ±0 Chromatokid (talk | contribs) convert a hard-coded date to the house format [rollback]
  5. (diff | hist) 03:13 Peptide harm reduction 2,785 +33 DrTitration (talk | contribs) add category for pricing [rollback]
  6. (diff | hist) m b 01:47 Arcuate nucleus 3,773 +36 StubSorterBot (talk | contribs) bot: sort category members [rollback]

11 January 2025

  1. (diff | hist) 22:00 TRIUMPH trial programme 3,396 +559 NNT_Nerys (talk | contribs) state the analysis population: intention-to-treat or per-protocol [rollback]
  2. (diff | hist) m b 17:51 Trial data comparison 1,546 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) m b 13:04 Dose escalation schedule 2,870 ±0 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) m 12:00 Cagrilintide 3,147 +177 ConsensusConal (talk | contribs) add the excipient list from the labelling [rollback]
  5. (diff | hist) 10:27 Purity claim inflation 3,067 ±0 Chromatokid (talk | contribs) expand §What a purity figure does establish [rollback]
  6. (diff | hist) 10:26 Talk:Sangon Biotech 1,033 +75 ScopeSeverin (talk | contribs) /* Scope: is this a peptide supplier article at all? */ reply
  7. (diff | hist) 06:18 Melanotan II 2,703 +192 TriumphThad (talk | contribs) add the stability data with the storage condition it was measured at [rollback]
  8. (diff | hist) m 01:24 List of GLP-1 receptor agonists 3,023 +157 Chromatokid (talk | contribs) add see-also entries for the four articles that link here [rollback]
  9. (diff | hist) m 00:35 Dual incretin agonist 4,587 +16 IcodecIndra (talk | contribs) add a hatnote pointing at the analogue with the similar name [rollback]

10 January 2025

  1. (diff | hist) 23:12 Sarcopenia 2,319 +29 CRP_Cormac (talk | contribs) expand §Definition and assessment [rollback]
  2. (diff | hist) 20:06 VendorInvestigate 3,483 +43 LeanMassLars (talk | contribs) clarify that a signature on a certificate is a release, not a verification [rollback]
  3. (diff | hist) 18:12 Liquid chromatography-mass spectrometry 3,315 +673 NauseaNoor (talk | contribs) clarify the difference between related substances and total impurities [rollback]
  4. (diff | hist) m 13:24 Glucose-dependent insulinotropic polypeptide 6,231 ±0 IncretinIvo (talk | contribs) correct the direction of the effect on gastric emptying [rollback]
  5. (diff | hist) 11:04 Reconstitution of lyophilised peptides 4,173 +471 SharpsSukhi (talk | contribs) expand §Concentration arithmetic [rollback]
  6. (diff | hist) 10:57 Third-party testing 5,061 ±0 UnderfillUna (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  7. (diff | hist) 09:36 Peptide supply chain 4,143 +131 ColdChainCleo (talk | contribs) ce, tighten prose [rollback]
  8. (diff | hist) m b 07:23 Orforglipron 3,337 +434 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]
  9. (diff | hist) 02:00 Satiety signalling 4,078 +104 ReceptorRhoda (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]

9 January 2025

  1. (diff | hist) m 23:34 Counterfeit peptide 2,322 +256 VerifyFirstVida (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  2. (diff | hist) m 19:12 Residual solvent 3,607 +727 IncretinIvo (talk | contribs) add the plate-count expression and define its terms [rollback]
  3. (diff | hist) 12:49 Haemoglobin A1c 3,218 ±0 B12_Bettina (talk | contribs) copyedit [rollback]
  4. (diff | hist) m 11:02 Enteroendocrine L cell 4,107 +641 IncretinIvo (talk | contribs) expand §GLP-1 synthesis and secretion [rollback]
  5. (diff | hist) 09:52 Talk:Sangon Biotech 822 +208 NotabilityNoa (talk | contribs) /* Scope: is this a peptide supplier article at all? */ reply
  6. (diff | hist) 09:05 Reverse-phase HPLC 4,246 +362 SecondarySrc_Seb (talk | contribs) add category for method validation [rollback]

8 January 2025

  1. (diff | hist) m 21:15 GLP-1 receptor agonist 8,171 +49 GsCouplingGil (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]
  2. (diff | hist) 20:16 Bacterial endotoxin test 4,102 +123 INN_Ingrid (talk | contribs) expand §Methods [rollback]
  3. (diff | hist) 19:42 USP General Chapter 85 2,668 ±0 ChromCleanupCass (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  4. (diff | hist) 14:45 Amino acid analysis 2,621 ±0 ReaderRosalie (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  5. (diff | hist) 14:31 Talk:Sangon Biotech 611 +214 ParentCatPansy (talk | contribs) /* Scope: is this a peptide supplier article at all? */ reply
  6. (diff | hist) m 13:45 Preparative HPLC purification 3,843 +453 RepackRadek (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  7. (diff | hist) 11:20 Regulatory status by jurisdiction 2,721 ±0 UACR_Ulric (talk | contribs) add the customs-detention point with its source [rollback]
  8. (diff | hist) 11:04 Talk:Sangon Biotech 400 +295 ScopeSeverin (talk | contribs) /* Scope: is this a peptide supplier article at all? */ new section
  9. (diff | hist) N 09:00 Global access disparity 1,977 +1,977 DisparityDagny (talk | contribs) new article: access and cost, expansion welcome
  10. (diff | hist) m 08:48 SURMOUNT trial programme 3,270 +133 CommaCarys (talk | contribs) copyedit [rollback]
  11. (diff | hist) m 02:08 LEADER trial 3,178 +45 ReportReaderRilla (talk | contribs) add the discontinuation rate for adverse events in both arms [rollback]